Published: September 02, 2009
Tyrian Diagnostics First Sales of ReadRite ImmunoScanner to Bayer CropScience AG
SYDNEY - (BUSINESS WIRE) - Tyrian Diagnostics Limited (ASX:TDX) announced today that it has
completed manufacture and delivery of an initial order of ReadRite
ImmunoScanners to Bayer CropScience AG ("Bayer" ). The ReadRite
ImmunoScanner will be used with the ReadRite-Alpha Amylase test kit to
provide Bayer customers with a rapid, easy to use, and quantitative
method for determining the quality of wheat at Point of Need. Each
ReadRite ImmunoScanner is able to process several thousand test kits.
The majority of the ReadRite ImmunoScanners will be distributed into
Canada to support Bayer's efforts in the ReadRite Alpha-Amylase product
launch and initial market roll-out in North America. The balance will be
delivered to other countries to commence market seeding of ReadRite
products.
"The launch of the ReadRite product is a major accomplishment for
Tyrian, and validates our DiagnostIQ platform in the agriculture
industry," said Jenny Harry, PhD, CEO, Tyrian Diagnostics. Production
planning is now underway to support the product's forecast demands for
the next twelve months.
The ReadRite ImmunoScanner is central to Bayer's launch of a ReadRite
diagnostic product portfolio, with the Alpha-Amylase test being the
first product to be commercialised using this technology. Over the next
12 months, the technology and product scope will be expanded to include
multiple test applications in line with the product pipeline, with a
second test currently in co-development with Bayer for commercialisation.
"The successful delivery of the co-branded ReadRite ImmunoScanners
comes after a rigorous internal design verification and validation
program of the hardware, software and system to ensure compliance to the
product's internal design specifications and the global regulatory
compliance requirements," commented Michelle Gow, Tyrian's Head of
Product Development & Regulatory Affairs. Compliance with the mandatory
standards required for CE mark (Europe), RoHS (Europe), FCC Part 15 (US
47 CFR §15) and C-Tick (Australia) creates a pathway for the product to
be marketed in other regions such as Europe and Australia.
About Tyrian's DiagnostIQ Reader
Tyrian's DiagnostIQ Reader is a proprietary device that utilises optical
detection technology combined with customized software to provide a
quantitative measure of the level of diagnostic targets in samples
processed in Tyrian's point of need DiagnostIQ tests. The Reader can be
configured to detect diagnostic targets in a wide range of sample types,
and therefore has utility in the healthcare, agricultural, and
veterinary fields. Currently, the Reader is marketed by Bayer as the
ReadRite ImmunoScanner for use with the ReadRite Alpha-Amylase test
for wheat quality, developed and manufactured by Tyrian.
About Tyrian Diagnostics
Tyrian Diagnostics (ASX:TDX) is a diagnostics company with expertise in
biomarker discovery and validation and diagnostic test development and a
core focus on respiratory and infectious diseases. In addition, Tyrian
can partner in alternative fields given its capabilities to work across
the entire spectrum of diagnostic test development - from identification
and isolation of biomarkers, point-of-need test design, clinical
development or field testing to final product. Tyrian's product pipeline
includes: ReadRite for measuring wheat quality, which is partnered with
Bayer CropScience; and a rapid test for active tuberculosis, in
collaboration with Becton Dickinson and Company.
Additional information about Tyrian Diagnostics can be found at www.tyriandx.com
Tyrian Diagnostics
Dr. Jenny Harry, +61 2 8877 8947
Chief
Executive Officer
Copyright © 2012, Business Wire, Inc., All rights reserved.
Copyright © 2012, NewsBlaze,
Daily News
Search News
